| Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas (NCT07778602) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-11-10 |
| Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer (NCT07580339) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-10-01 |
| DK222 Study at Hopkins (NCT07140315) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-09-01 |
| A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) (NCT07430202) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-08-01 |
| PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT (NCT07550517) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-08-01 |
| Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors (NCT07360119) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-08-01 |
| Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE) (NCT07424222) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-07-15 |
| Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer (NCT07281768) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-07-14 |
| Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ (NCT06210854) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-06-25 |
| Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM) (NCT07375992) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-05-26 |
| Precision Radiotherapy Enabled by Molecular MRI (NCT07512154) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-04-29 |
| Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia (NCT07071155) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-03-19 |
| Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response (NCT07142551) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-03-09 |
| Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) (NCT07209189) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-02-18 |
| Physician- and Patient-based Barriers to NGS Testing (NCT07209176) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-01-06 |
| Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer (NCT04243473) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-01-01 |
| Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients (NCT06138067) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-12-01 |
| Pediatric Radiation Therapy Registry (NCT07129317) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-10-31 |
| Exercise in Prostate Cancer (NCT06165302) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-10-16 |
| PSMA Therapy and Immunotherapy in Kidney Cancer (NCT06361810) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-10-01 |
| NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer (NCT06941857) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-09-04 |
| The COSMYC Trial (COmbined Suppression of MYC) (NCT06922318) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-08-19 |
| A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients (NCT06315257) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-07-23 |
| 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer (NCT06826924) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-06-03 |
| Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) (NCT06564623) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-05-27 |
| Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer (NCT06782932) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-05-27 |
| Proton SBRT for Spinal Metastasis (NCT06895564) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-04-22 |
| A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma (NCT06610682) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-04-07 |
| Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) (NCT06803745) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-03-27 |
| Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma (NCT06796543) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-03-25 |
| Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma (NCT06376669) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-02-25 |
| Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer (NCT06616597) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-02-13 |
| 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma (NCT06322576) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-02-10 |
| Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer (NCT06617923) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-02-06 |
| SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization (NCT06389097) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-02-03 |
| Renal Retention in High Grade Upper Tract Urothelial Cancer (NCT05656235) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-11-25 |
| Study in Patients With Breast Cancer Leptomeningeal Metastasis (NCT06638294) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-11-25 |
| KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer (NCT06411691) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-11-04 |
| Brachytherapy Innovations in Gynecologic Cancer (NCT04530019) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-10-01 |
| Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies (NCT06398457) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-09-19 |
| Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming (NCT06536881) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-08-08 |
| Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers (NCT06001658) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-07-08 |
| Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions (NCT06463249) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-06-17 |
| Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma (NCT06463262) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-06-14 |
| Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer (NCT06205836) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-06-13 |
| Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma (NCT06122480) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-05-21 |
| Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC (NCT05950139) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-05-13 |
| PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC (NCT06245889) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-05-01 |
| Pre-operative Hypofractionated Proton Therapy (NCT05917301) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-04-18 |
| Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer (NCT06014255) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-02-16 |
| DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) (NCT06027086) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-02-12 |
| A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer (NCT05574712) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-01-01 |
| Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). (NCT05977907) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-12-14 |
| Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients (NCT03372148) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-12-01 |
| Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML (NCT05716009) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-11-20 |
| Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers (NCT04713046) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-18 |
| Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection (NCT06508138) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-18 |
| Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (NCT06059118) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-10-04 |
| Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT (NCT03861676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-08-03 |
| Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients (NCT05823571) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-07-06 |
| Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer (NCT05501548) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-06-30 |
| Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients (NCT05658731) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-05-17 |
| Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer (NCT04799431) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-05-03 |
| Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab (NCT05472623) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-03-21 |
| 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM) (NCT04926168) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-03-01 |
| Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection (NCT05585684) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-01-27 |
| Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS (NCT05302570) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-12-01 |
| RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis (NCT05298358) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-11-18 |
| KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC (NCT05254184) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-11-01 |
| Post-transplant Flotetuzumab for AML (NCT05506956) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-10-20 |
| SMART-ER: Symptom Monitoring With Patient-reported Outcomes (NCT05560685) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-10-03 |
| Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma (NCT05083754) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-08-31 |
| Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer (NCT05014776) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-08-22 |
| Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer (NCT05312671) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-06-27 |
| Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma (NCT05025423) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-06-21 |
| Cardiometabolic Screening Program (NCT05386719) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-06-03 |
| Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma (NCT05141513) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-05-06 |
| Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT04704505) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-28 |
| Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer (NCT05013216) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-11 |
| Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors (NCT05121545) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-06 |
| Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer (NCT05081193) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-03-07 |
| Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma (NCT05103722) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-02-17 |
| Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell (NCT07062549) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-01-26 |
| Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca (NCT04988074) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-12-13 |
| Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. (NCT04753879) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-09-29 |
| Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma (NCT04301778) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-24 |
| HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors (NCT04979000) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-03 |
| Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban (NCT04895553) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-01 |
| TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers (NCT05132803) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-01 |
| Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor (NCT04465643) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-06-08 |
| Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients (NCT04843306) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-06-03 |
| Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC) (NCT04658147) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-05-28 |
| Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca (NCT04848116) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-04-24 |
| Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery (NCT04117074) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-04-14 |
| Trial to Promote Recovery From COVID-19 With Endocrine Therapy (NCT04374279) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-04-01 |
| Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer (NCT04892303) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-03-17 |
| Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study (NCT04499950) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-02-08 |
| Camostat With Bicalutamide for COVID-19 (NCT04652765) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-02-03 |
| PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04524195) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-02-01 |
| [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer (NCT04528199) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-02-01 |